Subscribe to RSS

DOI: 10.1055/a-2764-4702
Identification of an intramuscular gastric subepithelial stromal tumor during endoscopic resection by using endoscopic ultrasound within the submucosal tunnel
Authors
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract [1]. The management includes endoscopic resection (ER), surgery and oncological medical treatment [2].
We report the case of an 80-year-old woman with a subepithelial lesion of the greater gastric curve ([Video 1]). During endoscopic ultrasound (EUS), it appeared as an oval, hypoechoic homogeneous 29 mm lesion with hypervascularization on contrast-enhanced-EUS, originating from the muscular layer [3]. Fine needle biopsy histology revealed a G1 GIST [4].
An endoscopic image showing marking of the gastrointestinal stromal tumor by using a linear echoendoscope advanced through the submucosal tunnel with an argon plasma coagulation probe during submucosal tunnel endoscopic resection.Video 1The GIST was treated by using a submucosal tunnel endoscopic resection (STER) technique with an operative gastroscope (EG-760CT, Fujifilm corp. Tokyo, Japan) and a HybridKnife T-type I-jet (ERBE Elektromedizin, Tuebingen, Germany).
Initially, the lesion was visible as subepithelial bulging. After submucosal tunneling, the lesion was not clearly detectable both from inside and outside the tunnel, as it was located within the muscular layer and covered by muscular fibers. Thus, to identify the GIST, we performed an EUS by advancing a linear echoendoscope (EG-740UT, Fujifilm corp. Tokyo, Japan) through the submucosal tunnel. The GIST was then identified, marked with argon plasma coagulation 30W on the muscular layer ([Fig. 1], panels a–d) and removed after the selective dissection of the muscular fibers covering the lesion. At the end of the procedure, the tunnel was intact, and the access was completely closed with through-the-scope clips. Histology confirmed the G1 GIST.


To our knowledge, this is the first report of a GIST of the muscular gastric layer treated with STER, requiring intraprocedural identification with EUS performed from within the submucosal tunnel. Lesions originating from the deep gastric wall layer may be at a higher risk of ER failure, also due to possible difficulties in their identification during the procedure [5]. This approach could minimize this risk and ease the procedure, avoiding the need for more invasive treatments such as laparoscopy and endoscopic cooperative surgery.
Endoscopy_UCTN_Code_CCL_1AB_2AC_3AB
Contributorsʼ Statement
Leandro Corradino: Investigation, Writing – original draft. Dario Biasutto: Data curation, Investigation, Writing – review & editing. Benedetto Neri: Conceptualization, Investigation, Supervision, Writing – review & editing. Serena Stigliano: Validation. Cristina Lucidi: Visualization. Valeria DʼOvidio: Validation, Visualization. Francesco Maria Di Matteo: Supervision, Validation, Visualization, Writing – review & editing.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgement
We wish to thank Dr. Raimondo Cirino and Dr. Riccardo Grande for their technical support during the procedure.
-
References
- 1 Gupta P, Tewari M, Shukla HS. Gastrointestinal stromal tumor. Surg Oncol 2008; 17: 129-138
- 2 Yue L, Sun Y, Wang X. et al. Advances of endoscopic and surgical management in gastrointestinal stromal tumors. Front Surg 2023; 10: 1092997
- 3 Deprez PH, Moons LMG, OʼToole D. et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54: 412-429
- 4 Nagtegaal ID, Odze RD, Klimstra D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182-188
- 5 Yuan Y, Sun L, Zhou X. et al. Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case-control study. Gastric Cancer 2022; 25: 929-942
Correspondence
Publication History
Article published online:
20 January 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Gupta P, Tewari M, Shukla HS. Gastrointestinal stromal tumor. Surg Oncol 2008; 17: 129-138
- 2 Yue L, Sun Y, Wang X. et al. Advances of endoscopic and surgical management in gastrointestinal stromal tumors. Front Surg 2023; 10: 1092997
- 3 Deprez PH, Moons LMG, OʼToole D. et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54: 412-429
- 4 Nagtegaal ID, Odze RD, Klimstra D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182-188
- 5 Yuan Y, Sun L, Zhou X. et al. Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case-control study. Gastric Cancer 2022; 25: 929-942


